Advertisement

Chemistry

Mallinckrodt Laboratory
Chemistry

Harvard Settles Patent Infringement Lawsuit Against Samsung

Harvard agreed to dismiss a patent infringement lawsuit against Samsung, a South Korean tech conglomerate, and waived its rights to refile the suit on Monday.

The Nobel Prize Winner
Advising

Nobel Laureate Martin Karplus ’51 Remembered as Attentive Mentor, ‘Pioneering’ Chemist

Martin Karplus ’51 developed ground-breaking computer models to study chemical reactions and molecular dynamics, mentored hundreds of scientists, and won a Nobel Prize in Chemistry. But his love for the sciences began with another discipline — biology.

Chemistry Labs Construction
On Campus

Harvard Chemistry Lab Complex Undergoing Electrical, Drainage Renovations

Harvard is currently renovating its nearly 100-year-old Chemistry laboratory complex to address the facilities’ “aging electrical infrastructure and deficient stormwater system.”

Harvard Yard from Above
Research

Harvard Sues Samsung in Federal Court Over Patent Infringement

Harvard sued tech giant Samsung over patent infringement claims on Monday, alleging the company’s chip technology violates two patents owned by the University.

Moungi Bawendi
Science

One Small Quantum Dot, One Giant Leap for Nanoscience: Moungi Bawendi ’82 Wins Nobel Prize in Chemistry

Moungi G. Bawendi ’82 was among three scientists awarded the 2023 Nobel Prize in Chemistry “for the discovery and synthesis of quantum dots,” the Royal Swedish Academy of Sciences announced in a press release Wednesday morning.

Yoshito Kishi Lab
FAS

Yoshito Kishi, Organic Chemist Who Climbed ‘Mount Everest’ of Synthesis, Dies at 85

Yoshito Kishi, a Harvard emeritus chemistry professor known for his contributions to breast cancer treatment, died on Jan. 9.

DAY 5
FAS

Embattled Harvard Chemistry Professor Charles Lieber Retires

Charles M. Lieber, the Harvard chemistry professor convicted of lying to federal investigators in 2021, quietly retired last month, a Harvard spokesperson confirmed Tuesday.

Christopher Walsh Courtesy
Harvard Medical School

Christopher Walsh ’65, Renowned Biochemist and Harvard Medical School Professor, Dies at 78

Christopher Walsh ’65, a renowned biochemist and Harvard Medical School professor, died on Jan. 10 at the age of 78. Throughout his career, Walsh made significant contributions in the areas of enzyme function, metabolic pathways, and antibiotic biosynthesis.

Mallinckrodt Laboratory
Research

Professor of Chemical Biology Explores Quantum Topological Materials

Harvard Assistant Professor of Chemical Biology Suyang Xu is working towards expanding the application of topological materials — new materials in the quantum field with the potential to significantly improve our ways of saving information.

Lieber Retrial
Chemistry

Convicted Harvard Professor Charles Lieber Moves For New Trial to Rectify ‘Manifest Injustice’

Attorneys for Harvard professor Charles M. Lieber filed a motion Monday for an acquittal or new trial, over a month after he was convicted in federal court on six felony counts.

DAY 5
Crime

Following Charles Lieber’s Conviction, ‘Shock’ and Sadness Linger Among His Harvard Colleagues

Following Chemistry professor Charles M. Lieber’s conviction last month, Harvard scientists say they are “shocked” and “saddened” about the prolific research chemist's fall from grace — and apprehensive about the future of international scientific collaboration.

Massachusetts Supreme Judicial Court
Crime

Judges Skeptical as Lieber Reiterates Harvard Should Pay His Legal Fees in Appeal Hearing

Justices on the Supreme Judicial Court appeared skeptical Wednesday as lawyers for former Harvard Chemistry chair Charles M. Lieber — who is preparing for trial on federal criminal charges — argued on appeal that Harvard should be obligated to pay for his legal defense.

Mallinckrodt Laboratory
Research

Harvard Chemists Use Dyes as a New Data Storage Method

Harvard chemists developed a new data storage method using fluorescent dyes that may be much more durable and cost-efficient than traditional storage methods.

Lieber Graphic
Research

Lieber Prepares for Impending Trial on Federal Charges As He Battles Incurable Cancer

Attorneys for former Chemistry chair Charles M. Lieber said during a status conference that Lieber’s cancer diagnosis and deteriorating health call for an expedient trial.

Travis Blum
FAS

Harvard Researchers Reprogram Botox for Therapeutic Use for the First Time

Harvard researchers have evolved botulinum neurotoxins — commonly known as botox — to selectively target different proteins for the first time, presenting new opportunities for the potential treatment of a wide variety of medical conditions.

Advertisement